Health Care
Articles
Lilly licenses Xigris rights to new biotech firm
Eli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created local biotech company called BioCritica that will seek to reinvigorate sales of the medication.
OrthoIndy looks to loopholes for growth
OrthoIndy, the physician practice that owns the Indiana Orthopaedic Hospital, was able to open a new outpatient facility this spring by working around growth restrictions in the 2010 health care reform law. But its choices for further growth are much starker—which is why it’s lobbying to repeal that provision of the law.
IU Health buying docs in hospital ventures
Indiana University Health is now quietly unwinding the physician ownership of its hospitals in Carmel and Avon—which sparked loud controversy when they opened in 2004 and 2005.
Health insurers lose push to ease rate review
U.S. insurers led by WellPoint Inc. and UnitedHealth Group Inc. failed to get federal regulators to change a rule in the 2010 health-care overhaul that triggers a review of any premium increases exceeding 10 percent.
Franciscan Alliance takes control of VNS home health agency
Visiting Nurse Service Inc., a 200-employee agency based in Indianapolis, will operate under the umbrella of Franciscan St. Francis Health, the organizations announced Thursday.
Riley Hospital CEO resigns
Dan Fink, who joined Riley Hospital for Children nearly six years ago, will depart Friday. Marilyn Cox will serve as interim president and CEO while Riley conducts a national search for a new leader.
Growth in drug spending to slow as generics rise
The annual growth rate in spending on drugs may be cut in half over the next five years as people opt for less expensive generic medicines over brand-name treatments, a health-care research group said Wednesday, highlighting the challenge pharmaceutical firms like Eli Lilly and Co. are facing.
Prescription drug abuse growing problem in Indiana
Prescription drugs are playing an increasing role in the drug-related crimes that are filling up Indiana's prisons, prison officials and prosecutors said.
Amylin sues Lilly over drug development deal
Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim to develop and sell a competing product.
VCs: Health benefits will be defined contribution
Increasing government involvement in the health insurance market will have the counter-intuitive effect of making the industry more consumer-driven, concludes a new report from a health care venture-capital firm.
Health care providers opening to technology
Some health care system are finally allowing online scheduling.
MANTOOTH: Companies bogged down by employees’ poor health
The problem is, too many people make unhealthy choices and the consequences of these choices become everyone’s problem.
BISHOP: Warsaw’s orthopedics whizzes will master biologics
Industry cluster in northern Indiana has adapted to every other change in health care, and will absorb tissue regeneration, too.
Reform could create more ’boutique’ doctors
Health reform could accelerate trend toward two tiers of care, with concierge services like Dr. Matt Priddy offers at the top and long waits and minimal attention at the bottom.
Lilly drug to detect Alzheimer’s criticized by consumer group
Eli Lilly and Co.’s Amyvid, an experimental imaging agent to detect signs of Alzheimer’s disease in the brain, shouldn’t be approved because of unreliable study results, a consumer-advocacy group said.
IU Health LaPorte Hospital eliminates 112 jobs
Hospital President and chief executive officer Thor Thordarson said in a news release the jobs cuts were necessary because of the higher costs facing health care providers.
Medical device manufacturer seeks abatement
Indianapolis-based Medivative Technologies plans to build a 9,000-square-foot addition to its east-side facility and spend $2.5 million to equip it. The expansion should create 15 jobs.
FDA OKs new diabetes pill from Lilly, Boehringer
The Food and Drug Administration says it has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can't control their blood sugar with older medicines.
Economist: Expect boom in medical offices
Demand for medical office buildings is set to grow twice as fast as it was expected to in the next decade, thanks to the Patient Protection and Affordable Care Act.